Literature DB >> 22440259

Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study.

Kamarudin Ahmad1, Zoriah Aziz.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The consumption of Mitragyna speciosa (MS) for its psychoactive effects is widely reported amongst people in the villages in Thailand and Malaysia even though its use is illegal. AIM OF THE STUDY: This study examined the pattern of MS use, its reported effects and explored its potential to cause dependence.
MATERIALS AND METHODS: We used both convenience and snowball-sampling methods to recruit participants in a border town between two northern states in Malaysia. Face-to-face interviews were conducted with the use of a structured questionnaire on 562 respondents who gave oral consent to participate in the study.
RESULTS: The response rate was 91%. The majority of the respondents (88%) reported daily use of MS. The main mode of using MS was by drinking the MS extract as tea (90%). The mean age of starting MS use was 28.3 (SD=8.1) years. A variety of reasons were given for using MS including for social and recreational needs, stamina and physical endurance, pain relief and improved sexual performance. Despite its reported usefulness in weaning off opiate addiction, 460 (87%) admitted they were not able to stop using MS. Only education level had a statistically significant association with the ability to stop or not stop the use of MS (χ(2)=31.0, df=1, p<0.001). Significantly higher proportions of those with a lower education level (38%) were able to stop using MS compared to respondents with a higher education level.
CONCLUSIONS: Our study provides important information on the pattern of MS use, its effects and its potential to cause addiction, as there has been growing interest in MS as evidenced by the number of advertisements for its sale on the Internet. Future study is required to explore its psychological and social impact on users.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440259     DOI: 10.1016/j.jep.2012.03.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  30 in total

1.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

2.  Discriminative stimulus properties of mitragynine (kratom) in rats.

Authors:  Norsyifa Harun; Zurina Hassan; Visweswaran Navaratnam; Sharif M Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2015-01-25       Impact factor: 4.530

3.  The inhibitory effects of mitragynine on P-glycoprotein in vitro.

Authors:  Noradliyanti Rusli; Azimah Amanah; Gurjeet Kaur; Mohd Ilham Adenan; Shaida Fariza Sulaiman; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-02       Impact factor: 3.000

4.  Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats.

Authors:  Illa S Johari; Norsyifa Harun; Zarif M Sofian; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2021-08-01       Impact factor: 4.530

5.  Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.

Authors:  Norsyifa Harun; Illa Syafiqah Johari; Sharif Mahsufi Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2019-12-12       Impact factor: 4.530

6.  Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.

Authors:  Anne-Christin Stolt; Helmut Schröder; Hartmud Neurath; Gisela Grecksch; Volker Höllt; Markus R Meyer; Hans H Maurer; Nancy Ziebolz; Ursula Havemann-Reinecke; Axel Becker
Journal:  Psychopharmacology (Berl)       Date:  2013-07-12       Impact factor: 4.530

7.  Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.

Authors:  Rhiannon Bath; Tanner Bucholz; Amy F Buros; Darshan Singh; Kirsten E Smith; Charles A Veltri; Oliver Grundmann
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

Review 8.  The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder.

Authors:  Ismail Nurul Iman; Nurul Aiman Mohd Yusof; Ummi Nasrah Talib; Nur Aimi Zawami Ahmad; Anwar Norazit; Jaya Kumar; Muhammad Zulfadli Mehat; Nanthini Jayabalan; Sangu Muthuraju; Marzena Stefaniuk; Leszek Kaczmarek; Mustapha Muzaimi
Journal:  Front Behav Neurosci       Date:  2021-06-04       Impact factor: 3.558

9.  Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.

Authors:  Alicia G Lydecker; Abhisheak Sharma; Christopher R McCurdy; Bonnie A Avery; Kavita M Babu; Edward W Boyer
Journal:  J Med Toxicol       Date:  2016-10-17

10.  Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.

Authors:  Kirsten E Smith; Jeffrey M Rogers; Destiny Schriefer; Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.